Identifying a Deletion Affecting Total Lung Capacity Among Subjects in the COPDGene Study Cohort

Genetic Epidemiology

Volumn 40, Issue 1, 2016, Pages 81-88

  Begum, Ferdouse ^a   Ruczinski, Ingo ^a   Li, Shengchao ^b   Silverman, Edwin K ^c   Cho, Michael H ^c   Lynch, David A ^d   Curran Everett, Douglas ^d   Crapo, James ^d   Scharpf, Robert B ^e   Parker, Margaret M ^a   Hetmanski, Jacqueline B ^a   Beaty, Terri H ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d DEPARTMENT OF MEDICINE   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

COPD; Copy number variant (CNV); Genome wide association study (GWAS); Lung hyperinflation; Pulmonary function; Total lung capacity (TLCCT)

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CHROMOSOME 5Q; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; COPY NUMBER VARIATION; FAM153B GENE; FEMALE; GENE; GENE DELETION; GENE LOCATION; GENE LOCUS; GENETIC ASSOCIATION; GENOME ANALYSIS; HUMAN; LUNG CAPACITY; MAJOR CLINICAL STUDY; MALE; QUANTITATIVE ANALYSIS; SIMK1 GENE; TOTAL LUNG CAPACITY; CAUCASIAN; CHROMOSOME 5; CHROMOSOME DELETION; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; MARKOV CHAIN; MIDDLE AGED; SMOKING;

BIOLOGICAL MARKER;

AFRICAN AMERICANS; AGED; BIOMARKERS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 5; COHORT STUDIES; DNA COPY NUMBER VARIATIONS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MARKOV CHAINS; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; TOTAL LUNG CAPACITY;

EID: 84951795774     PISSN: 07410395     EISSN: 10982272     Source Type: Journal    
DOI: 10.1002/gepi.21943     Document Type: Article

References (41)

1. Cho MH, Boutaoui N, Klanderman BJ, Sylvia JS, Ziniti JP, Hersh CP, DeMeo DL, Hunninghake GM, Litonjua AA, Sparrow D and others. 2010. Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nat Genet 42(3):200-202.
2. Cho MH, Castaldi PJ, Wan ES, Siedlinski M, Hersh CP, Demeo DL, Himes BE, Sylvia JS, Klanderman BJ, Ziniti JP and others. 2012. A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13. Hum Mol Genet 21(4):947-957.
3. Cho MH, McDonald ML, Zhou X, Mattheisen M, Castaldi PJ, Hersh CP, Demeo DL, Sylvia JS, Ziniti J, Laird NM and others. 2014. Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis. Lancet Respir Med 2(3):214-225.
4. GT Consortium . 2013. The Genotype-Tissue Expression (GTEx) project. Nat Genet 45(6):580-585.
5. Derrien T, Estelle J, Marco Sola S, Knowles DG, Raineri E, Guigo R, Ribeca P. 2012. Fast computation and applications of genome mappability. PLoS One 7(1):e30377.
6. Dikow N, Maas B, Gaspar H, Kreiss-Nachtsheim M, Engels H, Kuechler A, Garbes L, Netzer C, Neuhann TM, Koehler U and others. 2013. The phenotypic spectrum of duplication 5q35.2-q35.3 encompassing NSD1: is it really a reversed Sotos syndrome? Am J Med Genet A 161A(9):2158-2166.
7. Diskin SJ, Li M, Hou C, Yang S, Glessner J, Hakonarson H, Bucan M, Maris JM, Wang K. 2008. Adjustment of genomic waves in signal intensities from whole-genome SNP genotyping platforms. Nucleic Acids Res 36(19):e126.
8. Estepar RW, Washko GG, Silverman EK, Reilly JJ, Kikinis R, Westin CF. 2006. Accurate airway wall estimation using phase congruency. Med Image Comput Comput Assist Interv 9(Pt 2):125-134.
9. Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering C and others. 2013. STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res 41(Database issue):D808-D815.
10. Gibson GJ. 1996. Pulmonary hyperinflation a clinical overview. Eur Respir J 9(12):2640-2649.
11. Grydeland TB, Dirksen A, Coxson HO, Pillai SG, Sharma S, Eide GE, Gulsvik A, Bakke PS. 2009. Quantitative computed tomography: emphysema and airway wall thickness by sex, age and smoking. Eur Respir J 34(4):858-865.
12. Heron M. 2015. Deaths: leading causes for 2011. Natl Vital Stat Rep 64(7):1-96.
13. Hersh CP, Washko GR, Jacobson FL, Gill R, Estepar RS, Reilly JJ, Silverman EK. 2007. Interobserver variability in the determination of upper lobe-predominant emphysema. Chest 131(2):424-431.
14. Hersh CP, Washko GR, Estepar RS, Lutz S, Friedman PJ, Han MK, Hokanson JE, Judy PF, Lynch DA, Make BJ and others. 2013. Paired inspiratory-expiratory chest CT scans to assess for small airways disease in COPD. Respir Res 14:42.
15. illumina. 2010. Interpreting infinium assay data for whole-genome structural variation. Techical Note: DNA Analysis.
16. Janssens W, Nuytten H, Dupont LJ, van Eldere J, Vermeire S, Lambrechts D, Nackaerts K, Decramer M, Cassiman JJ, Cuppens H. 2010. Genomic copy number determines functional expression of beta-defensin 2 in airway epithelial cells and associates with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 182(2):163-169.
17. Klaassens M, Morrogh D, Rosser EM, Jaffer F, Vreeburg M, Bok LA, Segboer T, van Belzen M, Quinlivan RM, Kumar A and others. 2014. Malan syndrome: Sotos-like overgrowth with de novo NFIX sequence variants and deletions in six new patients and a review of the literature. Eur J Hum Genet 23(5):610-615.
18. Ko JM. 2013. Genetic syndromes associated with overgrowth in childhood. Ann Pediatr Endocrinol Metab 18(3):101-105.
19. Lee BY, Cho S, Shin DH, Kim H. 2011. Genome-wide association study of copy number variations associated with pulmonary function measures in Korea Associated Resource (KARE) cohorts. Genomics 97(2):101-105.
20. Lee JW MM, Cho MH, Wan ES, Castaldi PJ, Hunninghake GM, Marchetti N, Lynch DA, Crapo JD, Lomas DA, Coxson HO and others. 2014. DNAH5 is associated with total lung capacity in chronic obstructive pulmonary disease. Respiratory Resch 15(97-106).
21. Leo A, Walker AM, Lebo MS, Hendrickson B, Scholl T, Akmaev VR. 2012. A GC-wave correction algorithm that improves the analytical performance of aCGH. J Mol Diagn 14(6):550-559.
22. O'Donnell D. 2008. [Dynamic lung hyperinflation and its clinical implication in COPD]. Rev Mal Respir 25(10):1305-1318.
23. Ono Y, Iemura S, Novak SM, Doi N, Kitamura F, Natsume T, Gregorio CC, Sorimachi H. 2013. PLEIAD/SIMC1/C5orf25, a novel autolysis regulator for a skeletal-muscle-specific calpain, CAPN3, scaffolds a CAPN3 substrate, CTBP1. J Mol Biol 425(16):2955-2972.
24. Parker MM, Foreman MG, Abel HJ, Mathias RA, Hetmanski JB, Crapo JD, Silverman EK, Beaty TH, Investigators CO. 2014. Admixture mapping identifies a quantitative trait locus associated with FEV1/FVC in the COPDGene Study. Genet Epidemiol 38(7):652-659.
25. Peiffer DA, Le JM, Steemers FJ, Chang W, Jenniges T, Garcia F, Haden K, Li J, Shaw CA, Belmont J and others. 2006. High-resolution genomic profiling of chromosomal aberrations using Infinium whole-genome genotyping. Genome Res 16(9):1136-1148.
26. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J and others. 2005. Interpretative strategies for lung function tests. Eur Respir J 26(5):948-968.
27. Pruim RJ, Welch RP, Sanna S, Teslovich TM, Chines PS, Gliedt TP, Boehnke M, Abecasis GR, Willer CJ. 2010. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 26(18):2336-2337.
28. Regan EA, Hokanson JE, Murphy JR, Make B, Lynch DA, Beaty TH, Curran-Everett D, Silverman EK, Crapo JD. 2010. Genetic epidemiology of COPD (COPDGene) study design. COPD 7(1):32-43.
29. Rual JF, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, Li N, Berriz GF, Gibbons FD, Dreze M, Ayivi-Guedehoussou N and others. 2005. Towards a proteome-scale map of the human protein-protein interaction network. Nature 437(7062):1173-1178.
30. Scharpf RB, Beaty TH, Schwender H, Younkin SG, Scott AF, Ruczinski I. 2012. Fast detection of de novo copy number variants from SNP arrays for case-parent trios. BMC Bioinformatics 13:330.
31. Scharpf RB, Mireles L, Yang Q, Kottgen A, Ruczinski I, Susztak K, Halper-Stromberg E, Tin A, Cristiano S, Chakravarti A and others. 2014. Copy number polymorphisms near SLC2A9 are associated with serum uric acid concentrations. BMC Genet 15:81.
32. The ARIC Investigators. 1989. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol 129(4):687-702.
33. Vestbo J, Anderson W, Coxson HO, Crim C, Dawber F, Edwards L, Hagan G, Knobil K, Lomas DA, MacNee W and others. 2008. Evaluation of COPD longitudinally to identify predictive surrogate end-points (ECLIPSE). Eur Respir J 31(4):869-873.
34. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M and others. 2013. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 187(4):347-365.
35. Wain LV, Odenthal-Hesse L, Abujaber R, Sayers I, Beardsmore C, Gaillard EA, Chappell S, Dogaru CM, McKeever T, Guetta-Baranes T and others. 2014. Copy number variation of the beta-defensin genes in Europeans: no supporting evidence for association with lung function, chronic obstructive pulmonary disease or asthma. PLoS One 9(1):e84192.
36. Wan ES, Hokanson JE, Murphy JR, Regan EA, Make BJ, Lynch DA, Crapo JD, Silverman EK, Investigators CO. 2011. Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study. Am J Respir Crit Care Med 184(1):57-63.
37. Wan ES, Castaldi PJ, Cho MH, Hokanson JE, Regan EA, Make BJ, Beaty TH, Han MK, Curtis JL, Curran-Everett D and others. 2014. Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene. Respir Res 15(1):89.
38. Wang K, Li M, Hadley D, Liu R, Glessner J, Grant SF, Hakonarson H, Bucan M. 2007. PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res 17(11):1665-1674.
39. Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, van der Grinten CP and others. 2005. Standardisation of the measurement of lung volumes. Eur Respir J 26(3):511-522.
40. Younkin SG, Scharpf RB, Schwender H, Parker MM, Scott AF, Marazita ML, Beaty TH, Ruczinski I. 2014. A genome-wide study of de novo deletions identifies a candidate locus for non-syndromic isolated cleft lip/palate risk. BMC Genet 15:24.
41. Zhu G, Warren L, Aponte J, Gulsvik A, Bakke P, Anderson WH, Lomas DA, Silverman EK, Pillai SG; ICGN investigators. 2007. The SERPINE2 gene is associated with chronic obstructive pulmonary disease in two large populations. Am J Respir Crit Care Med 176(2):167-173.